Effects of Medications on the Voice

Otolaryngologic Clinics of North America

Volumn 40, Issue 5, 2007, Pages 1081-1090

  Abaza, Mona M ^a   Levy, Steven ^b   Hawkshaw, Mary J ^c   Sataloff, Robert T ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Philadelphia Ear   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; AZATADINE; CIMETIDINE; CONJUGATED ESTROGEN; CORTICOSTEROID; CYTOCHROME P450; DANAZOL; DECONGESTIVE AGENT; FAMOTIDINE; FEXOFENADINE; FLUTICASONE PROPIONATE; GUAIFENESIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; LORATADINE; MEDROXYPROGESTERONE ACETATE; NIZATIDINE; OMEPRAZOLE; PHENYLPROPANOLAMINE; PROTON PUMP INHIBITOR; PSEUDOEPHEDRINE; RANITIDINE; SALMETEROL XINAFOATE; STEROID; STOMACH SECRETION INHIBITOR; UNINDEXED DRUG; ZIDOVUDINE;

ABDOMINAL PAIN; AGGRESSION; AGITATION; ANXIETY; BLURRED VISION; CLINICAL ASSESSMENT; CONFUSION; COUGHING; DELIRIUM; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG INHIBITION; ESOPHAGUS CANDIDIASIS; ESTROGEN THERAPY; EUPHORIA; FATIGUE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HOARSENESS; HOMEOPATHY; HOSTILITY; HUMAN; HYPOMANIA; HYPOTHYROIDISM; INCREASED APPETITE; INTESTINE ULCER; LARYNGOPHARYNGEAL REFLUX; MANIA; MENTAL DISEASE; MUCOSAL DRYNESS; MUSCLE CRAMP; MUSCLE SPASM; NAUSEA; NERVOUSNESS; PARANOIA; PHARYNGITIS; PSYCHOSIS; REVIEW; RISK FACTOR; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; THROAT IRRITATION; TOXICITY; TREMOR; VIOLENCE; VOICE; XEROSIS; XEROSTOMIA;

ANALGESICS; ANTI-ULCER AGENTS; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; NASAL DECONGESTANTS; PSYCHOSES, SUBSTANCE-INDUCED; VOICE; VOICE DISORDERS;

EID: 34548292023     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2007.05.010     Document Type: Review

References (17)

1. Othmer E., and Othmer S.C. The clinical interview using DSM-IV, vol. 1 (1994), American Psychiatric Press, Washington, DC p. 252-9
2. Bernstein J.G. Handbook of drug therapy in psychiatry (1995), Mosby, St. Louis (MO) p. 370-1, 546, 353, 384, 380-1, 346, 359
3. Sataloff R.T., Hawkshaw M.J., and Anticaglia J. Medications and the voice. In: Sataloff R.T. (Ed). Professional voice. The science and art of clinical care (2006), Plural Publishing, San Diego (CA) 905-924
4. Bazire S., and Benefield Jr. W.H. Psychotropic drug directory: the mental health professionals' handbook (1997), Quay Books, West Orange (NJ) p. 217-36, 179, 166
5. Buhl R. Local oropharyngeal side effects on inhaled corticosteroids inpatients with asthma. Allergy 61 5 (2006) 518-526
6. Stahl S.M. Psychopharmacology of antidepressants (1997), Dunitz Ltd., London p. 101-8
7. Sataloff R.T., Castell D.O., Sataloff D.M., et al. Reflux and other gastroenterologic conditions that may affect the voice. In: Sataloff R.T. (Ed). Professional voice. The science and art of clinical care. 2nd edition (1997), Singular Publishing Group, San Diego (CA) 319-329
8. Sataloff R.T., Castell D.O., Katz P.O., et al. Reflux laryngitis and related disorders (1999), Singular Publishing Group, San Diego (CA)
9. Yang Y., Lewis J.D., Epstein S., et al. Long term proton pump inhibitor therapy and risk of hip fracture. JAMA 296 24 (2006) 2947-2953
10. Canter T.G., and Korek J.S. Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med 114 (1991) 1027-1034
11. Rampello L., and Nicoletti G. The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia [Italian]. Medicina (Firenze) 10 (1990) 294-296
12. Slayden S.M. Risks of menopausal androgen supplement. Semin Reprod Endocrinol 16 2 (1998) 145-152
13. Abitbol J., Abitbol P., and Abitbol B. Sex hormones and the female voice. J Voice 13 3 (1999) 424-446
14. Van Lierde K.M., Claeys S., De Bodt M., et al. Response of the female vocal quality and resonance in professional voice users taking oral contraceptive pills: a multiparameter approach. Laryngoscope 116 10 (2006) 1894-1898
15. Marwali M.R., and Mehta J.L. COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies. Thromb Haemost 96 4 (2006) 401-406
16. Damste P.H. Changes in the voice caused by drugs. In: Meyer L., and Pach H.M. (Eds). Drug induced diseases (1978), Excerpta Medica, Amsterdam (The Netherlands) 543-548
17. Micromedex® healthcare series [Internet database]. Greenwood Village (CO): Thomson Micromedex. Updated periodically.